A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.
GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...
The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, ...
Analysts see greater upside in Novavax, while Moderna carries a ‘Hold’ rating despite stronger gains over the past year. ・Moderna was in focus after updated cancer vaccine data, while Novavax drew ...
Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...
Acceptance of respiratory syncytial virus (RSV) immunizations in the United States is growing, particularly for older adults, ...
Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...
In its August announcement, FDA's Center for Biologics Evaluation and Research (CBER) pointed to more than 20 cases of ...
Gaithersburg’s Novavax has struck a deal to give Pfizer the rights to its adjuvant technology — for a potential $530 million ...
Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...
US officials have confirmed that a government web page warning about the risks of unproved therapies claiming to treat autism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results